People with hard-to-treat asthma often have to use medicines such as systemic steroids that broadly suppress the immune system. Ryan M. Pearson, PhD, Associate Professor of Pharmaceutical Sciences and Director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy (UMSOP), is leading a team of researchers to develop new asthma treatments that don’t compromise patient’s overall immune responsiveness.
Read more
